A carregar...
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
Androgen deprivation therapy (ADT) is a key management strategy for prostate cancer (PC), achieved commonly by administration of luteinizing hormone-releasing hormone agonist (LHRHa), ADT markedly suppresses both male and female sex hormones which results in “castration syndrome”, a constellation of...
Na minha lista:
| Publicado no: | South Asian J Cancer |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4418092/ https://ncbi.nlm.nih.gov/pubmed/25992351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.155699 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|